|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu H, Xiong Y, Wang H, Yang L, Wang C,
Liu X, Wu Z, Li X, Ou L, Zhang R and Zhu X: Effects of water
extract from epimedium on neuropeptide signaling in an
ovariectomized osteoporosis rat model. J Ethnopharmacol.
221:126–136. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang C, Chen G, Wong J, Liu H, Xong Y,
Wang P, Yang L, Zhu X and Zhang Rl: Effect of herba epimedium
extract on bone mineral density and microstructure in
ovariectomised rat. J Pharm Biomed Sci. 6:275–278. 2016.
|
|
4
|
Zhang M, Zhang Y, Zhang L and Tian Q:
Mushroom polysaccharide lentinan for treating different types of
cancers: A review of 12 years clinical studies in China. Prog Mol
Biol Transl Sci. 163:297–328. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tian Y, Yi W, Bai L, Zhang P, Si J, Hou X,
Deng Y and Hou J: Lentinan in-situ coated tungsten oxide nanorods
as a nanotherapeutic agent for low power density photothermal
cancer therapy. Int J Biol Macromol. 137:904–911. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Meng X, Liang H and Luo L: Antitumor
polysaccharides from mushrooms: A review on the structural
characteristics, antitumor mechanisms and immunomodulating
activities. Carbohydr Res. 424:30–41. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kidd PM: The use of mushroom glucans and
proteoglycans in cancer treatment. Altern Med Rev. 5:4–27.
2000.PubMed/NCBI
|
|
8
|
Xia S, Zhang X, Li C and Guan H: Oridonin
inhibits breast cancer growth and metastasis through blocking the
Notch signaling. Saudi Pharm J. 25:638–643. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gui Z, Luo F, Yang Y, Shen C, Li S and Xu
J: Oridonin inhibition and miR200b-3p/ZEB1 axis in human pancreatic
cancer. Int J Oncol. 50:111–120. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang W, Huang Q and Hua ZC: Oridonin: A
promising anticancer drug from China. Front Biol. 5:540–545.
2010.
|
|
11
|
Wang ZN, Wo XD and Zhou YL: Molecule
mechanisms of Oridonin on tumors chemoprevention and therapy. China
Medical Herald. 28:14–16. 2008.(In Chinese).
|
|
12
|
Yang J, Jiang H, Wang C, Yang B, Zhao L,
Hu D, Qiu G, Dong X and Xiao B: Oridonin triggers apoptosis in
colorectal carcinoma cells and suppression of microRNA-32
expression augments oridonin-mediated apoptotic effects. Biomed
Pharmacother. 72:125–134. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xu T, Jin F, Wu K, Ye Z and Li N: Oridonin
enhances in vitro anticancer effects of lentinan in SMMC-7721 human
hepatoma cells through apoptotic genes. Exp Ther Med. 14:5129–5134.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sun Z, Han Q, Duan L, Yuan Q and Wang H:
Oridonin increases anticancer effects of lentinan in HepG2 human
hepatoblastoma cells. Oncol Lett. 15:1999–2005. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang H, Mo S, Yang L, Wang P, Sun K, Xiong
Y, Liu H, Liu X, Wu Z, Ou L, et al: Effectiveness associated with
different therapies for senile osteopo-rosis: A network
Meta-analysis. J Tradit Chin Med. 40:17–27. 2020.PubMed/NCBI
|
|
16
|
Li R, Xiao C, Liu H, Huang Y, Dilger JP
and Lin J: Effects of local anesthetics on breast cancer cell
viability and migration. BMC Cancer. 18(666)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li X, Peng B, Zhu X, Wang P, Xiong Y, Liu
H, Sun K, Wang H, Ou L, Wu Z, et al: Changes in related circular
RNAs following ERβ knockdown and the relationship to rBMSC
osteogenesis. Biochem Biophys Res Commun. 493:100–107.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu X, Liu H, Xiong Y, Yang L, Wang C,
Zhang R and Zhu X: Postmenopausal osteoporosis is associated with
the regulation of SP, CGRP, VIP, and NPY. Biomed Pharmacother.
104:742–750. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Amikishieva AV, Ilnitskaya SI, Nikolin VP,
Popova NA and Kaledin VI: Depressive-like psychoemotional state
versus acute stresses enhances Lewis lung carcinoma metastasis in
C57BL/6J mice. Exp Oncol. 33:222–225. 2011.PubMed/NCBI
|
|
20
|
Qian Y, Wang D, Fan M, Xu Y, Sun X and
Wang J: Effects of intrinsic metal ions of lentinan with different
molecular weights from Lentinus edodes on the antioxidant capacity
and activity against proliferation of cancer cells. Int J Biol
Macromol. 120:73–81. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang XE, Wang YH, Zhou Q, Peng M, Zhang J,
Chen M, Ma LJ and Xie GM: Immunomodulatory effect of lentinan on
aberrant T subsets and cytokines profile in non-small cell lung
cancer patients. Pathol Oncol Res. 26:499–505. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu H, Dilger JP and Lin J: Effects of
local anesthetics on cancer cells. Pharmacol Ther.
212(107558)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li R, Liu H, Dilger JP and Lin J: Effect
of propofol on breast cancer cell, the immune system, and patient
outcome. BMC Anesthesiol. 18(77)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li R, Huang Y, Liu H, Dilger JP and Lin J:
Comparing volatile and intravenous anesthetics in a mouse model of
breast cancer metastasis. Cancer Res. 78(2162)2018.
|
|
25
|
Liu H: A clinical mini-review: Clinical
use of Local anesthetics in cancer surgeries. G Med Sci. 1:030–034.
2020.
|
|
26
|
Liu H, Dilger JP and Lin J: The role of
transient receptor potential melastatin 7 (TRPM7) in cell
viability: A potential target to suppress breast cancer cell cycle.
Cancers (Basel). 12(131)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Van Opdenbosch N and Lamkanfi M: Caspases
in cell death, inflammation, and disease. Immunity. 50:1352–1364.
2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu W, Gu J, Qi J, Zeng XN, Ji J, Chen ZZ
and Sun XL: Lentinan exerts synergistic apoptotic effects with
paclitaxel in A549 cells via activating ROS-TXNIP-NLRP3
inflammasome. J Cell Mol Med. 19:1949–1955. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bao L, Wang Y, Ma R, Ren X, Cheng R and B
A: Apoptosis-inducing effects of lentinan on the proliferation of
human bladder cancer T24 cells. Pak J Pharm Sci. 28:1595–1600.
2015.PubMed/NCBI
|
|
30
|
Siddiqui WA, Ahad A and Ahsan H: The
mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update.
Arch Toxicol. 89:289–317. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wawryk-Gawda E, Chylińska-Wrzos P,
Lis-Sochocka M, Chłapek K, Bulak K, Jędrych M and Jodłowska-Jędrych
B: P53 protein in proliferation, repair and apoptosis of cells.
Protoplasma. 251:525–533. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang X, Simpson ER and Brown KA: p53:
Protection against tumor growth beyond effects on cell cycle and
apoptosis. Cancer Res. 75:5001–5007. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu H: A prospective for the potential
effect of Local Anesthetics on Stem-Like cells in colon cancer.
Biomed J Sci & Tech Res. 25:18927–18930. 2020.
|
|
35
|
Wu Z, Ou L, Wang C, Yang L, Wang P, Liu H,
Xiong Y, Sun K, Zhang R and Zhu X: Icaritin induces MC3T3-E1
subclone14 cell differentiation through estrogen receptor-mediated
ERK1/2 and p38 signaling activation. Biomed Pharmacother. 94:1–9.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen G, Wang C, Wang J, Yin S, Gao H,
Xiang LU, Liu H, Xiong Y, Wang P, Zhu X, et al: Antiosteoporotic
effect of icariin in ovariectomized rats is mediated via the
Wnt/β-catenin pathway. Exp Ther Med. 12:279–287. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu H, Xiong Y, Zhu X, Gao H, Yin S, Wang
J, Chen G, Wang C, Xiang L, Wang P, et al: Icariin improves
osteoporosis, inhibits the expression of PPARΥ, C/EBPα,
FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA
in ovariectomized rats. Exp Ther Med. 13:1360–1368. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Xiang Y, Guo Z, Zhu P, Chen J and Huang Y:
Traditional Chinese medicine as a cancer treatment: Modern
perspectives of ancient but advanced science. Cancer Med.
8:1958–1975. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu H, Dilger JP and Lin J: Lidocaine
suppresses viability and migration of human breast cancer cells:
TRPM7 as a target for some breast cancer cell lines. Cancers
(Basel). 13(234)2021.PubMed/NCBI View Article : Google Scholar
|
